|
Volumn 17, Issue 2, 2010, Pages 171-172
|
Immune therapy for chronic inflammatory demyelinating polyneuropathy: From clinical trials to real-life
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
IMMUNOGLOBULIN;
IMMUNOSUPPRESSIVE AGENT;
PLACEBO;
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY;
DIABETES MELLITUS;
DISABILITY;
DRUG COST;
DRUG EFFICACY;
EDITORIAL;
HUMAN;
IMMUNOTHERAPY;
MEDICAL DECISION MAKING;
MONOCLONAL IMMUNOGLOBULINEMIA;
PLASMAPHERESIS;
PRIORITY JOURNAL;
RANKIN SCALE;
TREATMENT FAILURE;
TREATMENT RESPONSE;
UNSPECIFIED SIDE EFFECT;
CLINICAL TRIALS AS TOPIC;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
IMMUNOLOGIC FACTORS;
IMMUNOTHERAPY;
POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;
STEROIDS;
TREATMENT OUTCOME;
|
EID: 74549215041
PISSN: 13515101
EISSN: 14681331
Source Type: Journal
DOI: 10.1111/j.1468-1331.2009.02804.x Document Type: Editorial |
Times cited : (2)
|
References (7)
|